Article
This is Your Thyroid on Drugs: Targetable Mutations and Fusions in Thyroid Carcinoma.
Clinics in laboratory medicine - 1 Sept 2026
Chu Ying-Hsia
Abstract excerpt
This review aims to provide an overview of the molecular pathogenesis thyroid carcinomas, emphasizing genetic alterations that are therapeutically actionable. The main pathways in thyroid carcinogenesis are the MAPK and PI3K pathways. Point mutations and gene rearrangements affecting the pathway effectors and receptor tyrosine kinases are well-known drivers of thyroid cancer. Research over the past few decades...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
